Turn spectrum scarcity into a software problem
SpectrumIQ uses real-time telemetry from your existing cell towers and ML-powered demand forecasting to dynamically reallocate frequencies across 50-100 sites, cutting congestion by 35% in dense urban zones. Built on Apache Kafka and ClickHouse for sub-second spectrum decisions, it delivers what fixed allocation can't: adaptive capacity that follows your users, not your legacy planning spreadsheets. Mid-market carriers reduce infrastructure CapEx by 20-30% by squeezing more throughput from licensed spectrum they already own.
Key Benefits:
- Real-time interference detection with gRPC-based mitigation reduces dropped calls by 40% during peak hours
- ML forecasting (TensorFlow on historical traffic patterns) predicts demand spikes 6-12 hours ahead, enabling proactive reallocation before congestion hits
- Single-pane React dashboard replaces manual frequency planning—engineers reallocate spectrum in 3 clicks vs. 3 days of RF analysis
MVP Scope: MVP focuses on a single mid-market carrier with 50-100 cell towers. Ingest real-time traffic metrics from existing network infrastructure, apply ML-based spectrum optimization to recommend dynamic frequency reallocation every 15 minutes, and display recommendations via a web dashboard. Target 15-20% capacity improvement in initial deployment with manual approval workflow for frequency changes.
Tech Stack: Apache Kafka, ClickHouse, Python/TensorFlow, PostgreSQL, React, Docker/Kubernetes, gRPC
Components:
- Real-time Network Telemetry Collector
- ML-powered Spectrum Optimization Engine
- Dynamic Frequency Allocation Dashboard
- Interference Detection & Mitigation System
- Capacity Planning & Forecasting Module
Quality assessment: Strong technical foundation with concrete value proposition (35% congestion reduction) and realistic MVP scope, but lacks originality—dynamic spectrum allocation is an established problem domain—and the artifact is incomplete (pitch cuts off mid-sentence), preventing assessment of full market positioning depth.
Comments
Sign in to join the conversation.
No comments yet. Be the first to share your thoughts.